Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

References for PMC Articles for PubMed (Select 19905037)

2.

Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study.

Mermin J, Were W, Ekwaru JP, Moore D, Downing R, Behumbiize P, Lule JR, Coutinho A, Tappero J, Bunnell R.

Lancet. 2008 Mar 1;371(9614):752-9. doi: 10.1016/S0140-6736(08)60345-1.

PMID:
18313504
3.

Rapid expansion of the health workforce in response to the HIV epidemic.

Samb B, Celletti F, Holloway J, Van Damme W, De Cock KM, Dybul M.

N Engl J Med. 2007 Dec 13;357(24):2510-4. No abstract available.

PMID:
18077816
4.

Cost-effectiveness of cotrimoxazole prophylaxis among persons with HIV in Uganda.

Pitter C, Kahn JG, Marseille E, Lule JR, McFarland DA, Ekwaru JP, Bunnell R, Coutinho A, Mermin J.

J Acquir Immune Defic Syndr. 2007 Mar 1;44(3):336-43.

PMID:
17327758
5.
6.

Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda.

Weidle PJ, Wamai N, Solberg P, Liechty C, Sendagala S, Were W, Mermin J, Buchacz K, Behumbiize P, Ransom RL, Bunnell R.

Lancet. 2006 Nov 4;368(9547):1587-94.

PMID:
17084759
7.

Antiretroviral therapy and HIV prevention in India: modeling costs and consequences of policy options.

Over M, Marseille E, Sudhakar K, Gold J, Gupta I, Indrayan A, Hira S, Nagelkerke N, Rao AS, Heywood P.

Sex Transm Dis. 2006 Oct;33(10 Suppl):S145-52.

PMID:
17003679
8.

Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire.

Goldie SJ, Yazdanpanah Y, Losina E, Weinstein MC, Anglaret X, Walensky RP, Hsu HE, Kimmel A, Holmes C, Kaplan JE, Freedberg KA.

N Engl J Med. 2006 Sep 14;355(11):1141-53.

9.

Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study.

Mermin J, Ekwaru JP, Liechty CA, Were W, Downing R, Ransom R, Weidle P, Lule J, Coutinho A, Solberg P.

Lancet. 2006 Apr 15;367(9518):1256-61.

PMID:
16631881
10.

The costs and benefits of private sector provision of treatment to HIV-infected employees in Kampala, Uganda.

Marseille E, Saba J, Muyingo S, Kahn JG.

AIDS. 2006 Apr 4;20(6):907-14.

PMID:
16549976
11.

Nonantiretroviral drug consumption by CD4 cell count in HIV-infected adults: a 5-year cohort study in Côte d'Ivoire.

Nombela N, Kouadio B, Toure S, Seyler C, Flori YA, Anglaret X.

J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):225-31.

PMID:
16394856
12.

Association between malaria and CD4 cell count decline among persons with HIV.

Mermin J, Lule JR, Ekwaru JP.

J Acquir Immune Defic Syndr. 2006 Jan 1;41(1):129-30. No abstract available.

PMID:
16340488
13.

Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda.

Bunnell R, Ekwaru JP, Solberg P, Wamai N, Bikaako-Kajura W, Were W, Coutinho A, Liechty C, Madraa E, Rutherford G, Mermin J.

AIDS. 2006 Jan 2;20(1):85-92.

PMID:
16327323
14.

Cost-effectiveness of highly active antiretroviral therapy in South Africa.

Badri M, Maartens G, Mandalia S, Bekker LG, Penrod JR, Platt RW, Wood R, Beck EJ.

PLoS Med. 2006 Jan;3(1):e4. Epub 2005 Dec 6.

15.

Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries.

Hogan DR, Baltussen R, Hayashi C, Lauer JA, Salomon JA.

BMJ. 2005 Dec 17;331(7530):1431-7. Epub 2005 Nov 10.

16.

Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa.

Coetzee D, Hildebrand K, Boulle A, Maartens G, Louis F, Labatala V, Reuter H, Ntwana N, Goemaere E.

AIDS. 2004 Apr 9;18(6):887-95.

PMID:
15060436
17.

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.

Jackson JB, Musoke P, Fleming T, Guay LA, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Owor M, Ducar C, Deseyve M, Mwatha A, Emel L, Duefield C, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Gigliotti M, Bray D, Mmiro F.

Lancet. 2003 Sep 13;362(9387):859-68.

PMID:
13678973
18.

Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda.

Gray RH, Li X, Wawer MJ, Gange SJ, Serwadda D, Sewankambo NK, Moore R, Wabwire-Mangen F, Lutalo T, Quinn TC; Rakai Project Group.

AIDS. 2003 Sep 5;17(13):1941-51.

PMID:
12960827
19.

Exploring the costs of a limited public sector antiretroviral treatment programme in South Africa.

Boulle A, Kenyon C, Skordis J, Wood R.

S Afr Med J. 2002 Oct;92(10):811-7.

PMID:
12432807
20.

Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence.

Creese A, Floyd K, Alban A, Guinness L.

Lancet. 2002 May 11;359(9318):1635-43. Review. Erratum in: Lancet 2002 Sep 14;360(9336):880.

PMID:
12020523
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk